INTRODUCTION
Work, which was begun in the author's laboratory in 1948, on the chemistry of various Iipid fractions of Mycobacteria and other acid-fast micro-organisms, has led to the identification and elucidation of the chemistry of a number of compounds having unusual structures and interesting biological activities. The principal compounds studied are branchedchain high molecular weight fatty acids, glycolipids and peptido-glycolipids. Some information on biosynthetic mechanisms in these series has also been obtained.
The infection of a healthy animal br human being by tuberde bacilli gives rise to several pathological manifestations, such as: (i) formation of tuberdes; (ii) establishment of a delayed type of hypersensitivity; (iii) loss of weight, haemorrhages, and death, due to the presence of a toxic factor; (iv) increased production of antihoclies; (v) development of resistance to a second infection.
Weshallsee that all ofthese pathological phenomena are due to particular Iipid fractions of the tuberde bacillus. Besides these, we shall consider also a new category of glycolipids which are typical for certain strains of Mycobacteria (see Table 1 ). 
TUBERCLE FORMATION

Branched-chain fatty acids
Branched-chain fatty acids and their derivatives seem to be the principal compounds producing the characteristic tuberdes observed in tuberculosis.
(I)
H 3 C-(CH 2 )n-CH-CH 2 -CH-(CH 2 ) 4 -CH-CH-CH 2 
It seems that compounds having only one methyl branching, such as (I) and (II), are devoid of biologica1 activity, whereas those with three or more methyl branchings, such as (111) and (IV), are potent producers of tuberdes (see the review by Asselineau 5 ) .
The structural determination of phthienoic and mycocerosic acids is due to Polgar, Cason, J. and C. Asselineau, and S. and E. Stenhagen, and cannot be described in detail here (for recent reviews, see refs. 6 and 7). Two different mechanisms of biosynthesis can be considered for the fatty acids with methyl side-chains: the "Birch mechanism " 8 , consisting of the fixation of a methy1 group (from methionine) onto a po1yacetic acid chain*
• Hofman and Liu' have shown that the cyclopropane ring of lactobacillic acid is formed in vivo by the fixation of a one carbon unit derived from formate onto cis-vaccenic acid; the fixation of methyl groups on aliphatic chains by this mechanism does not seem to have been observed yet. and the " propionic acid mechanism ", consisting of the condensation of a normal fatty acid in the a:-position of one molecule of propionic acid. Repetition of the condensation of propionic acid could give molecules such as (111) and (IV). This mechanism had been considered by Polgar and Robinson 10 , Robinson 11 , Woodward 12 , and Gerzon et al. 13 , and has been recently proven in its simplest form for the biosynthesis of a:-methylbutyric acid in the Ascaris 14 and for the formation of the branched chain of the antibiotic erythromycin 15 • 1s. Recent experiments of Gastambide and Grisebach (unpublished) have shown that propionic acid, when incubated with growing cultures of the non-virulent human strain H37 Ra, is incorporated in good yield into mycocerosic acid (IV).
For phthiocerol, which has been shown to be a mixture of two homologous glycols (IIa) and (llb) 2 , the following biosynthetic route can be postulated:
The dihydroxy-keto compound (V) has been isolated as one of the "companions " of phthiocerol and has been named phthiodolone 1 7 .
Garnpounds with lang side-chains
These are the so-called mycolic acids: the latter have been defined as "high molecular weight ß-hydroxy acids with a long side-chain in a: " 18 • Three principal groups of mycolic acids have been described so far: (i) corynomycolic acid 19 and corynomycolenic acid 20 , of Corynebacterium diphtheriae, with 32 carbon atoms; (ii) the nocardic acids, of Nocardia asterozdes, with 50 ± 3 carbon atoms 21 ; (iii) the mycolic acids of Mycobacteria, with more than 80 carbon atoms 1 • a, 22. We have studied in detail the biosynthesis of the simplest of these acids, corynomycolic acid; this compound, C 32 H 64 0 3 , m.p. 70°, [a:]n = + 7·5°, has been isolated from "the Iipids of C. diphtheriae and C. ovis. Its structure (VI) has been established by degradation 19 and confirmed by synthesis 23 • (VI) (VII)
The presence of free palmitic acid and of palmitone in the lipids of C. diphtheriae 25 , as weil as previous work on the mycolic acids of Mycobacteria, suggested that corynomycolic acid is formed in vivo by the condensation of two molecules of palmitic acid (probably as palmitoyl-coenzyme A) and reduction ofthe intermediate ß-ketoester. Pairnitone (VII) could be formed through saponification and decarboxylation of the ß-ketoester.
Recent experiments of Gastambide-Odier 24 with 1-14 0-palmitic acid have confirmed this hypothesis, and have shown that corynomycolic acid is, in fact, formed in vivo by the condensation of two molecules of palmitic acid.
Oultures of diphtheria bacilli ( C. diphtheriae, strain Parke-Williams 8) were grown on Loiseau-Philippe medium containing 10 JLC of the potassium salt of 1-14 0-palmitic acid (specific activity (43·1 ± 6·0) X 107 counts min-1 mmo1e-
).
After 12 days at 37°, the cells were centrifuged, washed, and extracted wi th alcohol-ether ( 1 : 1).
Oorynomycolic acid was isolated in a pure state by chromatography on magnesium silicate-celite, esterification, distillation under reduced pressure, and finally chromatography of the methyl ester on alumina; after several subsequent stages of purification, 0-4 mg of pure methyl corynomycolate (m.p. 59-62 ·5° and specific activity 44·7 X 10 6 counts min-1 mmole- 1 ) were isolated. This represents about 3 per cent of the total radioactivity added with the potassium palmitate.
If corynomycolic acid is synthesized in vivo from two molecules of palmitic acid, then, in these experiments with carboxyl-labelled palmitic acid, only the 0-1 and 0-3 atoms should be labelled, and each should contain half of the radioactivity. This was proved to be the case experimentally, the reactions involved being represented schematically as follows:
The radioactive corynomycolic acid (VIa) was first diluted with authentic corynomycolic acid to a specific activity of (33·0 ± 4·0) X 10 4 counts mg-1 min-1 mmole-1 , and then oxidized and decarboxylated in a chromic acidacetic acid mixture. The barium carbonate obtained had a specific activity of (16·3 ± 6·4) X 10 4 counts min-1 mmole-I, and the palmitone (VII) obtained in a pure state (m.p. 79-80·5°) had the same specific activity ( (16·3 ± 2·3) X 10 4 ). This already shows that the carboxyl ofthe labelled corynomycolic acid has half the radioactivity of the whole molecule.
The radioactive palmitone (VII) was then degraded in the following way: the oxime (VIII) was prepared and rearranged to the amide (IX); this was cleaved in acidmedium and gave an inactive amine (XI) and palmitic acid (X) having the same specific activity ( (12·5 ± 3·4) X 10 4 ) as the palmitone; decarboxylation of this palmitic acid then gave again an inactive amine (XII) and barium carbonate having the same radioactivity as the initial sample of palmitone (VII).
This proves that, in the corynomycolic acid formed in vivo in the presence of l-14 C-palmitic acid, only the C-1 and C-3 atoms are radioactive; this can only be explained by the condensation of two intact molecules of palmitic acid; otherwise, if the palmitic acid had undergone an initial degradation, radioactivity would have been " smeared out " over the whole molecule.
It can be surmised that one of the molecules of palmitoyl-CoA has tobe carboxylated to tetradecylmalonyl-CoA. The detailed mechanism of the condensation reaction has not yet been studied.
Corynomycolenic acid (XIII), the second C 32 -mycolic acid isolated from C. diphtheriae 20 , is obviously formed from one molecule of palmitoleic acid, CH 3 -(CH 2 )s-CH=CH-(CH 2 h-COOH (which also exists in !arge quantities in the free state in the diphtheria bacillus), and one molecule of palmitic acid. Here, an intermediary ß-keto-ester could give a ketone, ~7-palmitenone, CH 3 -(CH 2 ) 5 -CH=CH-(CH 2 ) 7 -COC 15 H 31 , on saponification; this has also been isolated from the Iipids ofC. diphtheriae 25 
The nocardic acids, C 50 where R is a radical containing about 60 carbon atoms with one oxygen function (OH, or OCH 3 or a carbonyl) and three chains.
Extensive degradative evidence has shown that in some of these mycolic acids the second oxygen function is either on C-5 or further away from the carboxyl, and that C-4 or probably C-4 and C-6 carry side-chains 6 • 22 .
As to the length of the various side chains, it is known that at least one of these (besides that at C-o:) has 24 to 26 carbon atoms, and that the others are shorter (0 16 to C 18 ).
All experimental evidence is in agreement with formulae (XVII) and (XVIII), which could result from the condensation of four molecules of (XVIII)
The mycolonic acids 28 (some of which are 3-hydroxy-5-keto-compounds) can be considered as intermediates in this reduction.
Avian and saprophytic strains of Mycobacteria are incapable of synthesizing hexacosanoic acid; their Iongest chain free fatty acid is tetracosanoic acid; the mycolic acids of these strains have the general structure (XIX) 29 :
where R is a radical C 58 H 116 ± 3CH 2 with one hydroxyl group.
It may be mentioned also that Karlsson 30 has found mutants of Mycobacteria for which hexacosanoic acid acts as growth factor; it seems obvious that this latter acid is indispensable as starting material for the synthesis of mycolic acids.
We may sum up the actual knowledge of the biosynthesis of branchedchain compounds by Mycobacteria and Actinomycetes in general as follows: the condensation of a straight-chain (usually even-numbered) acid R'-COOH on the C-a: atom of an acid R"-CH 2 -COOH gives methylbranched fatty acids when R" is methyl, and gives mycolic acids when R" is a Ionger alkyl group.
Analogously to the biosynthesis of straight-chain fatty acids, these condensations can give ß-hydroxy-acids R'-CHOH-CHR"-COOH, which can be dehydrated to a:,ß-unsaturated acids R'-CH=CR"-COOH and reduced to saturated acids R'-CH 2 -CHR"-COOH. Examples of · one or the other of these three stages can be found in many bacterial Iipids*.
It is interesting that each mechanism of biosynthesis of fatty acids in acid-fast bacteria seems to have an optimum range of molecular size: normal fatty acid synthesis stops at C 26 , branched acids with several methyl groups have 21 to 34 carbon atoms, whereas mycolic acids have 32 to 88 carbon atoms.
Mycolic acids, as weil as their esters with carbohydrates, are potent producers of tuberdes in vivo 5 ; we shall see that glycolipids and peptidoglycolipids containing 50-88 per cent mycolic acid have other interesting biological activities.
DELAYED TYPE OF HYPERSENSITIVITY
The injection of tuberculin, a protein ( or mixture of proteins) secreted by the tuberde bacillus into the culture filtrate, is not sufficient to produce the typical "tuberculin hypersensitivity ". Raffel 31 has shown that one can elicit this hypersensitivity by simultaneaus injection of tuberculin and a purified wax fraction. I t was later found that all esters of mycolic acid with carbohydrates are active3 2 • Amongst the Iipids produced by tuberde bacilli, a particular wax fraction, called wax D, is also active in this respect. We shall say more about this fraction later.
THE TOXIC FACTOR
The toxic factor has been called " cord factor ", because it is found in " cord forming" organisms, i.e. virulent and attenuated strains which grow in the culture medium in" serpentine cords " 33 . One intravenous injection of 20p,g of natural cord factor kills mice within 10-20 days; haemorrhages in the lung are the principallesions observed.
Cord factor has been isolated in a pure state after repeated chromatographic purifications on magnesium silicate and silicic acid, and its structure The most specific method of obtaining 6,6' -diesters of trehalose is to heat 6,6'-ditosyl trehalose (XXIII), with two molecules of the potassium salt of an acid 37 Concerning the relation between chemical structure and cord factor activity, the following preliminary statements have been made 38 on the basis ·or unpublished experiments by Bloch with compounds prepared in the author's laboratory: 6-mycolates of monoses (n-glucose, n-galactose, n-glucosamine, e.g. (XXIVa, b)) are toxic, but to a lesser degree than trehalose esters; the corresponding 2-mycolates (XXV) and mycolamides (XXVI) arenot toxic.
0-COCH
The 6,6' -dimycolates of trehalose seem more active than the 6-monoor 2,6,6' -trimycolates.
Acetylation of the ß-hydroxyl of mycolic acid diminishes only slightly the activity of cord factor; fully acetylated cord factor is inactive.
The influence of the structure of the acid esterifying trehalose can be characterized as follows: even bebenie ( docosanoic) . esters of trehalose are active, but doses larger than 0·1 mg are necessary. The 6,6'-diester of trehalose with the synthetic mycolic acid C 44 H 88 0 3 (XXI) has about 50 per cent of the activity of natural cord factor. Dehydration of the latter acid gives the unsaturated acid (XXVII) :
(XXVII) which, as the 6,6'-diester oftrehalose, is inactive at 0·1 mg dose Ievels.
Concerning the mechanism of action of cord factor, Kato et al. 40 have found that injection of cord factor decreases the activity of most DPN-linked deh ydrogenases.
For reviews on cord factor, see Lederer 38 and Noll3 9 •
INCREASED PRODUCTION OF ANTIBODIES
Freund's adjuvant, consisting of a water-in-oil emulsion containing killed Mycobacteria in the oil phase and the antigen iri the aqueous phase, has been widely used by immunologists for increasing antibody production in animals. Freund 41 has reviewed our knowledge of the mode of action of this type of adjuvant.
After the preliminary experiments of White et al. 42 with a " purified wax fraction ", we showed with White et al. 43 that a particular wax fraction of human strains of M. tuberculosis can effectively replace the whole bacilli in Freund's adjuvant mixture.
This wax fraction, which we call wax D 5 -7 , is extracted from the bacilli with chloroform and can be separated from other wax fractions as a result of its insolubility in boiling acetone.
The wax D fractions of human strains of tuberde bacilli are high-melting dextrorotatory solids which represent 6-8 per cent of the dry weight of virulent strains, but only about 2 per cent of non-virulent strains 44 • Arecent study 4 5 of the chemical structure of wax D has shown that it is a high molecular weight Iipid, and that the composition and molecular weight varies from strain to strain. The best analysed wax D fraction, that of the human virulent strain "Brevannes ", has a molecular weight of about 54,000. On saponification, about 50 per cent of mycolic acid C 88 H 176 0 4 is obtained (corresponding to approximately 22 molecules) and 50 per cent of a water-soluble portion. This latter is a peptido-mucopolysaccharide and seems to be homogeneaus on ultracentrifugation and by immunological reactions.
The carbohydrate moiety of this peptido-mucopolysaccharide contains the following sugars: n-arabinose, n-mannose, n-galactose, glucosamine and galactosamine*; traces of muramic acid are present, probably as an impurity.
The peptide moiety of wax D of human strains is of particular interest, because the analogaus wax D fractions of bovine and saprophytic strains, which are nitrogen-free glycolipids, are inactive as adjuvants; thus, the peptide moiety seems to play a definite role in the adjuvant activity of wax D 43 • It had already been found several years ago that wax D fractions of all human strains investigated contain the same three amino-acids: mesodiaminopimelic acid, glutamic acid and alanine 6 • The particular wax D of the strain "Brevannes" which was studied in detail contains two molecules of meso-diaminopimelic acid (DAP), two molecules of n-glutamic acid (Glu) and three molecules of alanine (Ala), one of which is D. The presence of several amino-acids of" unnatural" configuration is quite remarkable. A tentative structure for wax D of the human virulent strain "Brevannes" of M. tuberculosis has been proposed 45 as follows: Quite recently, it has been shown that these seven molecules of aminoacids form a heptapeptide, and the sequence of amino-acids in this heptapeptide has been established as: meso-DAP.n-Ala.n-Glu.n-Glu.L-Ala.meso-DAP.L-Ala47.
From the products of the partial acid hydrolysis of the water-soluble part of wax D, a compound was isolated containing one molecule of meso-DAP, one of galactosamine and one of arabinose. Galaetasamine was found to be linked to a carboxyl-group of meso-DAP. This shows that the heptapeptide is linked by a carboxyl from one of its meso-DAP molecules to galactosamine, which is itself joined by a glycosidic linkage with arabinose, one of the components of the polysaccharide moiety. A second linkage probably exists between one carboxyl-group of n-glutamic acid and ara binose 4 7 . It should be mentioned that delipidated bacterial residues of human, bovine, avian and saprophytic strains arealso active adjuvants; this can be explained by the fact that these residues contain essentially cell-walls. It is * The optical configuration of these amino-sugars has not yet beeil determined; however, Haworth et a/. 46 have found D-glucosamine in a "lipid-bound" polysaccharide of M. tuberculosis closely related to the polysaccharide of wax D.
known that mycobacterial cell-walls are mainly composed of three aminoacids (alanine, glutamic acid, and o:, ~-diaminopimelic acid) linked to a polysaccharide containing arabinose, mannose, galactose and muramic acid 48 • They thus have an overall composition very similar to that of the water-soluble part of wax D of human strains.
The adjuvant activity of wax D of the human strain of M. tuberculosis is probably due to its general chemical analogy with the cell-wall, and one might consider the cellular reactions which result in the increase of antibody production as a general reaction of the tissues of the higher organism to contact with mycobacterial cell-walls.
DEVELOPMENT OF RESISTANCE TO INFECTION
Boquet and Negre 49 • 50 of the Pasteur Institute, Paris, have shown long ago that methanol extraction of acetone-defatted tuberde bacilli yields an extract which possesses immunizing properties. They had called this crude fraction "antigene methylique ", and Macheboeuf et al. 51 had shown that phospholipids are the main antigenic components of this extract.
More recently, Weiss and Dubos 52 have confirmed the findings of Boquet and Negre 49 , and have studied the preparation of active extracts and some biological aspects of immunization.
In view of the interesting biological properties of the crude phospholipid fraction, we have undertaken a more detailed study of its constituents.
It was already known from the work of Anderson 1 that mycobacterial phospholipids contain inositol and mannose. We have found with Mrs Vilkas that a phosphatidyl-inosito-dimannoside is the principal component of these phospholipids, and we have proposed for this compound formula (XXVIII), in which inositol is Iinked to the C-1 or C-3 atom of the mesoinositol, and in which the exact position of the 6-0-o:-n-mannopyranosidoo:-n-mannopyranose is not yet known 53 • The fatty acid molecules linked to glycerol are normal and methyl-branched 0 16 to 0 19 -fatty acids.
The phosphatidyl-inosito-dimannoside is accompanied by other phospholipids, amongst which a phosphatidyl-pentamannoside 54 • 55 and a phosphatidyl-pentaglucoside56 are most remarkable.
In the course ofrecent immunization experiments conducted in collaboration with Bloch, Vilkas obtained fractions of phospholipids which produce (in 20 p.g doses) a distinct increase in survival time of mice; the main constituent of these high-melting, strongly dextrorotatory fractions seems to be a phosphatidyl-inosito-trimannoside*.
THE MYCOSIDES, TYPE-SPECIFIC GLYCOLIPIDS
Smith et al. 57 • 58 , using the combined techniques of chromatography and infra-red spectroscopy, were able to show that some Iipid compounds are limi ted in distribu tion to a single species of micro-organism; their presence or absence may thus serve to distinguish between various species of Mycobacteria.
The distribution ofthese substances in the various species ofMycobacteria is as follows 58 : (i) phthiocerol dimycocerosate is present in the Iipids of 28 out of the 30 human strains studied; (ii) a compound, first called GB, is present in all 7 bovine strains studied; (iii) a compound, first called GA, is present in all 17 photochromogenic strains studied; (iv) a compound, calledJav, is present in 11 out of 13 avian strains, and also in 3 out of6 nonphotochromogenic strains.
As it was then shown 59 that compounds GA, ÜB and Jav are glycolipids, containing characteristic 0-methylated 6-deoxyhexoses in glycosidic linkage, it was suggested that these compounds be called "mycosides "; a mycoside is defined as a " type specific glycolipid of mycobacterial origin " 60 • Mycoside A ( the form er GA) is a nearly colourless solid, melting a t 1 05 o, Mycoside C differs from the other mycosides by its nitrogen content, which is due to the presence of several amino-acids; mycoside C is a peptidoglycolipid; as a matter of fact, it is a mixture of closely-related compounds which can be separated by chromatography on silicic acid; three of the fractions thus obtained have been investigated in more detail (see Table 2 )6 1 •
The peptide portion of these three fractions con tains three different amino-acids linked in a pentapeptide: one molecule of n-phenylalanine * More recently, the immunizing activity of this faction has been rather irregular. (Phe), two rnolecules of-n-allo-threonine (Thr) and two rnolecules of n-alanine(Ala); the pentapeptide offraction III/7 + 8 has the structure:
n-Phe.n-allo-Thr.n-Ala.n-allo-Thr .n-Ala. The unnatural configuration of all the constituent arnino-acids, and the presence of n-allo-threonine (which had not previously been isolated from natural sources), are rernarkable features6 2 • These rnycoside C preparations contain three different 6-deoxyhexoses: 6-deoxytalose, 3-0-rnethyl-6-deoxytalose and 3,4-di-0-rnethylrharnnose (MacLennan 63 ). It can be seen frorn Table 2 that fraction 1/17 contains four rnolecules of deoxy}lexoses, whereas the other two fractions contain three rnolecules.
The Iipid rnoiety of these rnycoside C preparations has not yet been fully characterized; it seerns to be a rnixture of saturated .and unsaturated hydroxyacids, the approxirnate rnolecular forrnula of the saturated acids varying frorn C 20 H 40 0 3 to C 30 H 60 0 3 • Two 0-acetyl groups arealso present in each of these fractions. For fraction III/7 + 8, the tentative structure (XXIX) has been proposed: In this structure, the terminal carboxyl group of o-alanine is not free but esterified with a hydroxyl group of one of the sugar molecules. As the three mycoside C fractions studied all have two molecules ofo~allo-threonine and two 0-acetyl groups, it is assumed that the acetyl groups are esterified to the hydroxyl groups of allo-threonine. Amongst the apparently type-specific Iipids, we might also mention a sugar-free peptido-lipid isolated from the pathogenic Actinomycete Nocardia asteroides 64 ; this fraction is a mixture of closely related compounds, m.p.
215-217°;
[a]o = + 44·5°, consisting of 30 per cent of a Iipid moiety of approximate molecular formula C 3 2 H 64 0 2 , j oined by an amide linkage to an oligopeptide containing the following six amino-acids: threonine, alanine, valine, isoleucine, leueine and proline. Two-thirds of the alanine and isoleueine are o-; here again the presence of o-amino~acids is noteworthy62.
CONCLUSION
In the course of a detailed study of the relations between biological activity and chemical structure of bacteriallipids, we have determined the structure, and mechanism ofbiosynthesis, ofhigh molecular weight branchedchain hydroxyacids. New types of glycolipids and peptido-glycolipids have been isolated, and their chemical structures have been defined; their interesting biological activities have been characterized.
The simultaneaus presence of several lipophilic and hydrophilic groups in the same molecule confers to glyco-and peptido-glycolipids peculiar physicochemical properties (such as emulsification, detergent action, etc .
•.• ) which might explain many of their biological activities and which open new fields of investigation.
Whereas n-amino acids had previously been known to exist only in antibiotics and in bacterial cell-walls, the work described above shows that they are also frequent constituents of liposoluble bacterial products, such as peptido-and peptido-glycolipids. This might indicate a close biochemical and physiological relationship of these products with cell-wall.
